CD200


Journal

Nature immunology
ISSN: 1529-2916
Titre abrégé: Nat Immunol
Pays: United States
ID NLM: 100941354

Informations de publication

Date de publication:
23 Feb 2024
Historique:
received: 15 03 2023
accepted: 30 01 2024
medline: 24 2 2024
pubmed: 24 2 2024
entrez: 24 2 2024
Statut: aheadofprint

Résumé

Fibroblasts are important regulators of inflammation, but whether fibroblasts change phenotype during resolution of inflammation is not clear. Here we use positron emission tomography to detect fibroblast activation protein (FAP) as a means to visualize fibroblast activation in vivo during inflammation in humans. While tracer accumulation is high in active arthritis, it decreases after tumor necrosis factor and interleukin-17A inhibition. Biopsy-based single-cell RNA-sequencing analyses in experimental arthritis show that FAP signal reduction reflects a phenotypic switch from pro-inflammatory MMP3

Identifiants

pubmed: 38396288
doi: 10.1038/s41590-024-01774-4
pii: 10.1038/s41590-024-01774-4
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : Deutsche Forschungsgemeinschaft (German Research Foundation)
ID : RA 2506/4-2
Organisme : Deutsche Forschungsgemeinschaft (German Research Foundation)
ID : RA 2506/7-1
Organisme : Deutsche Forschungsgemeinschaft (German Research Foundation)
ID : CRC1181/C6
Organisme : Deutsche Forschungsgemeinschaft (German Research Foundation)
ID : CRC/TRR 369
Organisme : Deutsche Forschungsgemeinschaft (German Research Foundation)
ID : SO 1735/2-1
Organisme : Deutsche Forschungsgemeinschaft (German Research Foundation)
ID : Clinician Scientist Program NOTICE
Organisme : EC | EU Framework Programme for Research and Innovation H2020 | H2020 Priority Excellent Science | H2020 European Research Council (H2020 Excellent Science - European Research Council)
ID : 853508 - BARRIER BREAK
Organisme : Innovative Medicines Initiative (IMI)
ID : HIPPOCRATES
Organisme : Innovative Medicines Initiative (IMI)
ID : RTCure
Organisme : Bundesministerium für Bildung, Wissenschaft, Forschung und Technologie (Federal Ministry for Education, Science, Research and Technology)
ID : MASCARA

Informations de copyright

© 2024. The Author(s), under exclusive licence to Springer Nature America, Inc.

Références

Davidson, S. et al. Fibroblasts as immune regulators in infection, inflammation and cancer. Nat. Rev. Immunol. 21, 704–717 (2021).
pubmed: 33911232 doi: 10.1038/s41577-021-00540-z
Croft, A. P. et al. Distinct fibroblast subsets drive inflammation and damage in arthritis. Nature 570, 246–251 (2019).
pubmed: 31142839 pmcid: 6690841 doi: 10.1038/s41586-019-1263-7
Wei, K. et al. Notch signalling drives synovial fibroblast identity and arthritis pathology. Nature 582, 259–264 (2020).
pubmed: 32499639 pmcid: 7841716 doi: 10.1038/s41586-020-2222-z
Armaka, M. et al. Single-cell multimodal analysis identifies common regulatory programs in synovial fibroblasts of rheumatoid arthritis patients and modeled TNF-driven arthritis. Genome Med. 14, 78 (2022).
pubmed: 35879783 pmcid: 9316748 doi: 10.1186/s13073-022-01081-3
Yan, M. et al. ETS1 governs pathological tissue-remodeling programs in disease-associated fibroblasts. Nat. Immunol. 23, 1330–1341 (2022).
pubmed: 35999392 doi: 10.1038/s41590-022-01285-0
Floudas, A. et al. Distinct stromal and immune cell interactions shape the pathogenesis of rheumatoid and psoriatic arthritis. Ann. Rheum. Dis. annrheumdis-2021-221761 (2022).
Mizoguchi, F. et al. Functionally distinct disease-associated fibroblast subsets in rheumatoid arthritis. Nat. Commun. 9, 789 (2018).
pubmed: 29476097 pmcid: 5824882 doi: 10.1038/s41467-018-02892-y
Ospelt, C. & Gay, S. The role of resident synovial cells in destructive arthritis. Best. Pract. Res. Clin. Rheumatol. 22, 239–252 (2008).
pubmed: 18455682 doi: 10.1016/j.berh.2008.01.004
Komatsu, N. & Takayanagi, H. Mechanisms of joint destruction in rheumatoid arthritis - immune cell-fibroblast-bone interactions. Nat. Rev. Rheumatol. 18, 415–429 (2022).
pubmed: 35705856 doi: 10.1038/s41584-022-00793-5
Friščić, J. et al. The complement system drives local inflammatory tissue priming by metabolic reprogramming of synovial fibroblasts. Immunity 54, 1002–1021 (2021).
pubmed: 33761330 doi: 10.1016/j.immuni.2021.03.003
Schett, G., McInnes, I. B. & Neurath, M. F. Reframing immune-mediated inflammatory diseases through signature cytokine hubs. N. Engl. J. Med. 385, 628–639 (2021).
pubmed: 34379924 doi: 10.1056/NEJMra1909094
McInnes, I. B. & Schett, G. Pathogenetic insights from the treatment of rheumatoid arthritis. Lancet 389, 2328–2337 (2017).
pubmed: 28612747 doi: 10.1016/S0140-6736(17)31472-1
Schmidkonz, C. et al. Fibroblast activation protein inhibitor imaging in nonmalignant diseases: a new perspective for molecular imaging. J. Nucl. Med. 63, 1786–1792 (2022).
pubmed: 36109182 doi: 10.2967/jnumed.122.264205
Kuwert, T., Schmidkonz, C., Prante, O., Schett, G. & Ramming, A. FAPI PET opens a new window to understanding immune-mediated inflammatory diseases. J. Nucl. Med. 63, 1136–1137 (2022).
pubmed: 35393350 doi: 10.2967/jnumed.122.263922
Lindner, T. et al. Development of quinoline-based theranostic ligands for the targeting of fibroblast activation protein. J. Nucl. Med. 59, 1415–1422 (2018).
pubmed: 29626119 doi: 10.2967/jnumed.118.210443
Loktev, A. et al. Development of fibroblast activation protein-targeted radiotracers with improved tumor retention. J. Nucl. Med. 60, 1421–1429 (2019).
pubmed: 30850501 pmcid: 6785792 doi: 10.2967/jnumed.118.224469
Jansen, K. et al. Selective inhibitors of fibroblast activation protein (FAP) with a (4-quinolinoyl)-glycyl-2-cyanopyrrolidine sScaffold. ACS Med. Chem. Lett. 4, 491–496 (2013).
pubmed: 24900696 pmcid: 4027141 doi: 10.1021/ml300410d
Jansen, K. et al. Extended structure-activity relationship and pharmacokinetic investigation of (4-quinolinoyl)glycyl-2-cyanopyrrolidine inhibitors of fibroblast activation protein (FAP). J. Med. Chem. 57, 3053–3074 (2014).
pubmed: 24617858 doi: 10.1021/jm500031w
Dorst, D. N. et al. Targeting of fibroblast activation protein in rheumatoid arthritis patients: imaging and ex vivo photodynamic therapy. Rheumatology 61, 2999–3009 (2022).
pubmed: 34450633 doi: 10.1093/rheumatology/keab664
Ge, L. et al. Preclinical evaluation and pilot clinical study of [
pubmed: 35715613 doi: 10.1007/s00259-022-05836-3
Squair, J. W. et al. Confronting false discoveries in single-cell differential expression. Nat. Commun. 12, 5692 (2021).
pubmed: 34584091 pmcid: 8479118 doi: 10.1038/s41467-021-25960-2
Buechler, M. B. et al. Cross-tissue organization of the fibroblast lineage. Nature 593, 575–579 (2021).
pubmed: 33981032 doi: 10.1038/s41586-021-03549-5
Collins, F. L. et al. Taxonomy of fibroblasts and progenitors in the synovial joint at single-cell resolution. Ann. Rheum. Dis. 82, 428–437 (2022).
pubmed: 36414376 doi: 10.1136/ard-2021-221682
Burkhardt, D. B. et al. Quantifying the effect of experimental perturbations at single-cell resolution. Nat. Biotechnol. 39, 619–629 (2021).
pubmed: 33558698 pmcid: 8122059 doi: 10.1038/s41587-020-00803-5
Reshef, Y. A. et al. Co-varying neighborhood analysis identifies cell populations associated with phenotypes of interest from single-cell transcriptomics. Nat. Biotechnol. 40, 355–363 (2022).
pubmed: 34675423 doi: 10.1038/s41587-021-01066-4
Dann, E., Henderson, N. C., Teichmann, S. A., Morgan, M. D. & Marioni, J. C. Differential abundance testing on single-cell data using k-nearest neighbor graphs. Nat. Biotechnol. 40, 245–253 (2022).
pubmed: 34594043 doi: 10.1038/s41587-021-01033-z
Lange, M. et al. CellRank for directed single-cell fate mapping. Nat. Methods 19, 159–170 (2022).
pubmed: 35027767 pmcid: 8828480 doi: 10.1038/s41592-021-01346-6
Omata, Y. et al. Group 2 innate lymphoid cells attenuate inflammatory arthritis and protect from bone destruction in mice. Cell Rep. 24, 169–180 (2018).
pubmed: 29972778 doi: 10.1016/j.celrep.2018.06.005
Rauber, S. et al. Resolution of inflammation by interleukin-9-producing type 2 innate lymphoid cells. Nat. Med. 23, 938–944 (2017).
pubmed: 28714991 pmcid: 5575995 doi: 10.1038/nm.4373
Morabito, S., Reese, F., Rahimzadeh, N., Miyoshi, E. & Swarup, V. hdWGCNA identifies co-expression networks in high-dimensional transcriptomics data. Cell Rep. Methods 3, 100498 (2023).
pubmed: 37426759 pmcid: 10326379 doi: 10.1016/j.crmeth.2023.100498
Qiu, X. et al. Mapping transcriptomic vector fields of single cells. Cell 185, 690–711 (2022).
pubmed: 35108499 pmcid: 9332140 doi: 10.1016/j.cell.2021.12.045
Penkava, F. et al. Single-cell sequencing reveals clonal expansions of pro-inflammatory synovial CD8 T cells expressing tissue-homing receptors in psoriatic arthritis. Nat. Commun. 11, 4767 (2020).
pubmed: 32958743 pmcid: 7505844 doi: 10.1038/s41467-020-18513-6
Carlberg, K. et al. Exploring inflammatory signatures in arthritic joint biopsies with spatial transcriptomics. Sci. Rep. 9, 18975 (2019).
pubmed: 31831833 pmcid: 6908624 doi: 10.1038/s41598-019-55441-y
Smith, M. H. et al. Drivers of heterogeneity in synovial fibroblasts in rheumatoid arthritis. Nat. Immunol. 24, 1200–1210 (2023).
pubmed: 37277655 pmcid: 10307631 doi: 10.1038/s41590-023-01527-9
Zhao, E. et al. Spatial transcriptomics at subspot resolution with BayesSpace. Nat. Biotechnol. 39, 1375–1384 (2021).
pubmed: 34083791 pmcid: 8763026 doi: 10.1038/s41587-021-00935-2
Lories, R. J., Luyten, F. P. & de Vlam, K. Progress in spondylarthritis. Mechanisms of new bone formation in spondyloarthritis. Arthritis Res Ther. 11, 221 (2009).
pubmed: 19439035 pmcid: 2688182 doi: 10.1186/ar2642
Andreev, D. et al. Regulatory eosinophils induce the resolution of experimental arthritis and appear in remission state of human rheumatoid arthritis. Ann. Rheum. Dis. 80, 451–468 (2021).
pubmed: 33148700 doi: 10.1136/annrheumdis-2020-218902
Chen, Z., Bozec, A., Ramming, A. & Schett, G. Anti-inflammatory and immune-regulatory cytokines in rheumatoid arthritis. Nat. Rev. Rheumatol. 15, 9–17 (2019).
pubmed: 30341437 doi: 10.1038/s41584-018-0109-2
Filer, A. The fibroblast as a therapeutic target in rheumatoid arthritis. Curr. Opin. Pharmacol. 13, 413–419 (2013).
pubmed: 23562164 doi: 10.1016/j.coph.2013.02.006
Gorczynski, R. M., Chen, Z., Yu, K. & Hu, J. CD200 immunoadhesin suppresses collagen-induced arthritis in mice. Clin. Immunol. 101, 328–334 (2001).
pubmed: 11726225 doi: 10.1006/clim.2001.5117
Schmidkonz, C. et al. Disentangling inflammatory from fibrotic disease activity by fibroblast activation protein imaging. Ann. Rheum. Dis. 79, 1485–1491 (2020).
pubmed: 32719042 doi: 10.1136/annrheumdis-2020-217408
Aletaha, D. et al. 2010 rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative. Arthritis Rheum. 62, 2569–2581 (2010).
pubmed: 20872595 doi: 10.1002/art.27584
Taylor, W. et al. Classification criteria for psoriatic arthritis: development of new criteria from a large international study. Arthritis Rheum. 54, 2665–2673 (2006).
pubmed: 16871531 doi: 10.1002/art.21972
Rudwaleit, M. et al. The development of Assessment of SpondyloArthritis International Society classification criteria for axial spondyloarthritis (part II): validation and final selection. Ann. Rheum. Dis. 68, 777–783 (2009).
pubmed: 19297344 doi: 10.1136/ard.2009.108233
Toms, J. et al. Targeting fibroblast activation protein: radiosynthesis and preclinical evaluation of an
pubmed: 32332144 doi: 10.2967/jnumed.120.242958
Keffer, J. et al. Transgenic mice expressing human tumour necrosis factor: a predictive genetic model of arthritis. EMBO J. 10, 4025–4031 (1991).
pubmed: 1721867 pmcid: 453150 doi: 10.1002/j.1460-2075.1991.tb04978.x
Nussbaum, J. C. et al. Type 2 innate lymphoid cells control eosinophil homeostasis. Nature 502, 245–248 (2013).
pubmed: 24037376 pmcid: 3795960 doi: 10.1038/nature12526
Kouskoff, V. et al. Organ-specific disease provoked by systemic autoimmunity. Cell 87, 811–822 (1996).
pubmed: 8945509 doi: 10.1016/S0092-8674(00)81989-3
Liu, F., Song, Y. & Liu, D. Hydrodynamics-based transfection in animals by systemic administration of plasmid DNA. Gene Ther. 6, 1258–1266 (1999).
pubmed: 10455434 doi: 10.1038/sj.gt.3300947
Zhang, G., Budker, V. & Wolff, J. A. High levels of foreign gene expression in hepatocytes after tail vein injections of naked plasmid DNA. Hum. Gene Ther. 10, 1735–1737 (1999).
pubmed: 10428218 doi: 10.1089/10430349950017734
Schindelin, J. et al. Fiji: an open-source platform for biological-image analysis. Nat. Methods 9, 676–682 (2012).
pubmed: 22743772 doi: 10.1038/nmeth.2019
Hao, Y. et al. Integrated analysis of multimodal single-cell data. Cell 184, 3573–3587 (2021).
pubmed: 34062119 pmcid: 8238499 doi: 10.1016/j.cell.2021.04.048
Satija, R., Farrell, J. A., Gennert, D., Schier, A. F. & Regev, A. Spatial reconstruction of single-cell gene expression data. Nat. Biotechnol. 33, 495–502 (2015).
pubmed: 25867923 pmcid: 4430369 doi: 10.1038/nbt.3192
van den Brink, S. C. et al. Single-cell sequencing reveals dissociation-induced gene expression in tissue subpopulations. Nat. Methods 14, 935–936 (2017).
pubmed: 28960196 doi: 10.1038/nmeth.4437
Choudhary, S. & Satija, R. Comparison and evaluation of statistical error models for scRNA-seq. Genome Biol. 23, 27 (2022).
pubmed: 35042561 pmcid: 8764781 doi: 10.1186/s13059-021-02584-9
Stuart, T. et al. Comprehensive integration of single-cell data. Cell 177, 1888–1902 (2019).
pubmed: 31178118 pmcid: 6687398 doi: 10.1016/j.cell.2019.05.031
Korsunsky, I. et al. Fast, sensitive and accurate integration of single-cell data with Harmony. Nat. Methods 16, 1289–1296 (2019).
pubmed: 31740819 pmcid: 6884693 doi: 10.1038/s41592-019-0619-0
Hie, B., Bryson, B. & Berger, B. Efficient integration of heterogeneous single-cell transcriptomes using Scanorama. Nat. Biotechnol. 37, 685–691 (2019).
pubmed: 31061482 pmcid: 6551256 doi: 10.1038/s41587-019-0113-3
Gayoso, A. et al. A Python library for probabilistic analysis of single-cell omics data. Nat. Biotechnol. 40, 163–166 (2022).
pubmed: 35132262 doi: 10.1038/s41587-021-01206-w
Büttner, M., Miao, Z., Wolf, F. A., Teichmann, S. A. & Theis, F. J. A test metric for assessing single-cell RNA-seq batch correction. Nat. Methods 16, 43–49 (2019).
pubmed: 30573817 doi: 10.1038/s41592-018-0254-1
Mikolajewicz, N. et al. Multi-level cellular and functional annotation of single-cell transcriptomes using scPipeline. Commun. Biol. 5, 1142 (2022).
pubmed: 36307536 pmcid: 9616830 doi: 10.1038/s42003-022-04093-2
Wu, T. et al. clusterProfiler 4.0: a universal enrichment tool for interpreting omics data. Innovation 2, 100141 (2021).
pubmed: 34557778 pmcid: 8454663
Borcherding, N. et al. Mapping the immune environment in clear cell renal carcinoma by single-cell genomics. Commun. Biol. 4, 122 (2021).
pubmed: 33504936 pmcid: 7840906 doi: 10.1038/s42003-020-01625-6
Love, M. I., Huber, W. & Anders, S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 15, 550 (2014).
pubmed: 25516281 pmcid: 4302049 doi: 10.1186/s13059-014-0550-8
Korotkevich, G. et al. Fast gene set enrichment analysis. Preprint at bioRxiv https://doi.org/10.1101/060012 (2021).
Andreatta, M. & Carmona, S. J. UCell: robust and scalable single-cell gene signature scoring. Comput Struct. Biotechnol. J. 19, 3796–3798 (2021).
pubmed: 34285779 pmcid: 8271111 doi: 10.1016/j.csbj.2021.06.043
La Manno, G. et al. RNA velocity of single cells. Nature 560, 494–498 (2018).
pubmed: 30089906 pmcid: 6130801 doi: 10.1038/s41586-018-0414-6
Bergen, V., Lange, M., Peidli, S., Wolf, F. A. & Theis, F. J. Generalizing RNA velocity to transient cell states through dynamical modeling. Nat. Biotechnol. 38, 1408–1414 (2020).
pubmed: 32747759 doi: 10.1038/s41587-020-0591-3
Robinson, M. D., McCarthy, D. J. & Smyth, G. K. edgeR: a Bioconductor package for differential expression analysis of digital gene expression data. Bioinformatics 26, 139–140 (2010).
pubmed: 19910308 doi: 10.1093/bioinformatics/btp616
Amezquita, R. A. et al. Orchestrating single-cell analysis with Bioconductor. Nat. Methods 17, 137–145 (2020).
pubmed: 31792435 doi: 10.1038/s41592-019-0654-x
Jin, S. et al. Inference and analysis of cell–cell communication using CellChat. Nat. Commun. 12, 1088 (2021).
pubmed: 33597522 pmcid: 7889871 doi: 10.1038/s41467-021-21246-9
Kolde, R. Pheatmap: pretty heatmaps. R package version 1.0.10. https://cran.r-project.org/web/packages/pheatmap/index.html (2019).
Zanotelli, V. R. & Bodenmiller, B. ImcSegmentationPipeline: a pixel-classification-based multiplexed image segmentation pipeline. https://doi.org/10.5281/zenodo.3841961 (2022).
Ashhurst, T. M. et al. Integration, exploration, and analysis of high-dimensional single-cell cytometry data using Spectre. Cytometry A 101, 237–253 (2022).
pubmed: 33840138 doi: 10.1002/cyto.a.24350

Auteurs

Simon Rauber (S)

Department of Internal Medicine 3 - Rheumatology and Immunology, Friedrich-Alexander-University (FAU) Erlangen-Nürnberg and Universitätsklinikum Erlangen, Erlangen, Germany.
Deutsches Zentrum für Immuntherapie (DZI), Friedrich-Alexander-University (FAU) Erlangen-Nürnberg and Universitätsklinikum Erlangen, Erlangen, Germany.

Hashem Mohammadian (H)

Department of Internal Medicine 3 - Rheumatology and Immunology, Friedrich-Alexander-University (FAU) Erlangen-Nürnberg and Universitätsklinikum Erlangen, Erlangen, Germany.
Deutsches Zentrum für Immuntherapie (DZI), Friedrich-Alexander-University (FAU) Erlangen-Nürnberg and Universitätsklinikum Erlangen, Erlangen, Germany.

Christian Schmidkonz (C)

Department of Nuclear Medicine, Friedrich-Alexander-University (FAU) Erlangen-Nürnberg and Universitätsklinikum Erlangen, Erlangen, Germany.
Department of Industrial Engineering and Health, Technical University Amberg-Weiden, Institute of Medical Engineering, Weiden, Germany.

Armin Atzinger (A)

Department of Nuclear Medicine, Friedrich-Alexander-University (FAU) Erlangen-Nürnberg and Universitätsklinikum Erlangen, Erlangen, Germany.

Alina Soare (A)

Department of Internal Medicine 3 - Rheumatology and Immunology, Friedrich-Alexander-University (FAU) Erlangen-Nürnberg and Universitätsklinikum Erlangen, Erlangen, Germany.
Deutsches Zentrum für Immuntherapie (DZI), Friedrich-Alexander-University (FAU) Erlangen-Nürnberg and Universitätsklinikum Erlangen, Erlangen, Germany.

Christoph Treutlein (C)

Institute of Radiology, Friedrich-Alexander-University (FAU) Erlangen-Nürnberg and Universitätsklinikum Erlangen, Erlangen, Germany.

Samuel Kemble (S)

Rheumatology Research Group, Institute for Inflammation and Ageing, College of Medical and Dental Sciences, University of Birmingham, Queen Elizabeth Hospital, Birmingham, UK.
NIHR Birmingham Biomedical Research Center and Clinical Research Facility, University of Birmingham, Queen Elizabeth Hospital, Birmingham, UK.

Christopher B Mahony (CB)

Rheumatology Research Group, Institute for Inflammation and Ageing, College of Medical and Dental Sciences, University of Birmingham, Queen Elizabeth Hospital, Birmingham, UK.
NIHR Birmingham Biomedical Research Center and Clinical Research Facility, University of Birmingham, Queen Elizabeth Hospital, Birmingham, UK.

Manuel Geisthoff (M)

Department of Nuclear Medicine, Friedrich-Alexander-University (FAU) Erlangen-Nürnberg and Universitätsklinikum Erlangen, Erlangen, Germany.

Mario R Angeli (MR)

Department of Internal Medicine 3 - Rheumatology and Immunology, Friedrich-Alexander-University (FAU) Erlangen-Nürnberg and Universitätsklinikum Erlangen, Erlangen, Germany.
Deutsches Zentrum für Immuntherapie (DZI), Friedrich-Alexander-University (FAU) Erlangen-Nürnberg and Universitätsklinikum Erlangen, Erlangen, Germany.

Maria G Raimondo (MG)

Department of Internal Medicine 3 - Rheumatology and Immunology, Friedrich-Alexander-University (FAU) Erlangen-Nürnberg and Universitätsklinikum Erlangen, Erlangen, Germany.
Deutsches Zentrum für Immuntherapie (DZI), Friedrich-Alexander-University (FAU) Erlangen-Nürnberg and Universitätsklinikum Erlangen, Erlangen, Germany.

Cong Xu (C)

Department of Internal Medicine 3 - Rheumatology and Immunology, Friedrich-Alexander-University (FAU) Erlangen-Nürnberg and Universitätsklinikum Erlangen, Erlangen, Germany.
Deutsches Zentrum für Immuntherapie (DZI), Friedrich-Alexander-University (FAU) Erlangen-Nürnberg and Universitätsklinikum Erlangen, Erlangen, Germany.

Kai-Ting Yang (KT)

Department of Internal Medicine 3 - Rheumatology and Immunology, Friedrich-Alexander-University (FAU) Erlangen-Nürnberg and Universitätsklinikum Erlangen, Erlangen, Germany.
Deutsches Zentrum für Immuntherapie (DZI), Friedrich-Alexander-University (FAU) Erlangen-Nürnberg and Universitätsklinikum Erlangen, Erlangen, Germany.

Le Lu (L)

Department of Internal Medicine 3 - Rheumatology and Immunology, Friedrich-Alexander-University (FAU) Erlangen-Nürnberg and Universitätsklinikum Erlangen, Erlangen, Germany.
Deutsches Zentrum für Immuntherapie (DZI), Friedrich-Alexander-University (FAU) Erlangen-Nürnberg and Universitätsklinikum Erlangen, Erlangen, Germany.

Hannah Labinsky (H)

Department of Internal Medicine 3 - Rheumatology and Immunology, Friedrich-Alexander-University (FAU) Erlangen-Nürnberg and Universitätsklinikum Erlangen, Erlangen, Germany.
Deutsches Zentrum für Immuntherapie (DZI), Friedrich-Alexander-University (FAU) Erlangen-Nürnberg and Universitätsklinikum Erlangen, Erlangen, Germany.

Mina S A Saad (MSA)

Department of Internal Medicine 3 - Rheumatology and Immunology, Friedrich-Alexander-University (FAU) Erlangen-Nürnberg and Universitätsklinikum Erlangen, Erlangen, Germany.
Deutsches Zentrum für Immuntherapie (DZI), Friedrich-Alexander-University (FAU) Erlangen-Nürnberg and Universitätsklinikum Erlangen, Erlangen, Germany.

Charles A Gwellem (CA)

Department of Internal Medicine 3 - Rheumatology and Immunology, Friedrich-Alexander-University (FAU) Erlangen-Nürnberg and Universitätsklinikum Erlangen, Erlangen, Germany.
Deutsches Zentrum für Immuntherapie (DZI), Friedrich-Alexander-University (FAU) Erlangen-Nürnberg and Universitätsklinikum Erlangen, Erlangen, Germany.

Jiyang Chang (J)

Department of Internal Medicine 3 - Rheumatology and Immunology, Friedrich-Alexander-University (FAU) Erlangen-Nürnberg and Universitätsklinikum Erlangen, Erlangen, Germany.
Deutsches Zentrum für Immuntherapie (DZI), Friedrich-Alexander-University (FAU) Erlangen-Nürnberg and Universitätsklinikum Erlangen, Erlangen, Germany.

Kaiyue Huang (K)

Department of Internal Medicine 3 - Rheumatology and Immunology, Friedrich-Alexander-University (FAU) Erlangen-Nürnberg and Universitätsklinikum Erlangen, Erlangen, Germany.
Deutsches Zentrum für Immuntherapie (DZI), Friedrich-Alexander-University (FAU) Erlangen-Nürnberg and Universitätsklinikum Erlangen, Erlangen, Germany.

Eleni Kampylafka (E)

Department of Internal Medicine 3 - Rheumatology and Immunology, Friedrich-Alexander-University (FAU) Erlangen-Nürnberg and Universitätsklinikum Erlangen, Erlangen, Germany.
Deutsches Zentrum für Immuntherapie (DZI), Friedrich-Alexander-University (FAU) Erlangen-Nürnberg and Universitätsklinikum Erlangen, Erlangen, Germany.

Johannes Knitza (J)

Department of Internal Medicine 3 - Rheumatology and Immunology, Friedrich-Alexander-University (FAU) Erlangen-Nürnberg and Universitätsklinikum Erlangen, Erlangen, Germany.
Deutsches Zentrum für Immuntherapie (DZI), Friedrich-Alexander-University (FAU) Erlangen-Nürnberg and Universitätsklinikum Erlangen, Erlangen, Germany.

Rostyslav Bilyy (R)

Department of Histology, Cytology, Embryology, Danylo Halytsky Lviv National Medical University, Lviv, Ukraine.
Institute of Cellular Biology and Pathology 'Nicolae Simionescu', Bucharest, Romania.

Jörg H W Distler (JHW)

Department of Internal Medicine 3 - Rheumatology and Immunology, Friedrich-Alexander-University (FAU) Erlangen-Nürnberg and Universitätsklinikum Erlangen, Erlangen, Germany.
Deutsches Zentrum für Immuntherapie (DZI), Friedrich-Alexander-University (FAU) Erlangen-Nürnberg and Universitätsklinikum Erlangen, Erlangen, Germany.
Clinic for Rheumatology, University Hospital Düsseldorf, Heinrich-Heine University Düsseldorf, Düsseldorf, Germany.
Hiller Research Center, University Hospital Düsseldorf, Heinrich-Heine University Düsseldorf, Düsseldorf, Germany.

Megan M Hanlon (MM)

Molecular Rheumatology, School of Medicine, Trinity Biomedical Sciences Institute, Trinity College Dublin, Dublin, Ireland.

Ursula Fearon (U)

Molecular Rheumatology, School of Medicine, Trinity Biomedical Sciences Institute, Trinity College Dublin, Dublin, Ireland.

Douglas J Veale (DJ)

EULAR Centre for Arthritis & Rheumatic Diseases, St. Vincent's University Hospital, University College Dublin, Dublin, Ireland.

Frank W Roemer (FW)

Institute of Radiology, Friedrich-Alexander-University (FAU) Erlangen-Nürnberg and Universitätsklinikum Erlangen, Erlangen, Germany.

Tobias Bäuerle (T)

Institute of Radiology, Friedrich-Alexander-University (FAU) Erlangen-Nürnberg and Universitätsklinikum Erlangen, Erlangen, Germany.

Hans M Maric (HM)

Rudolf-Virchow-Center for Integrative and Translational Imaging, University of Würzburg, Würzburg, Germany.

Simone Maschauer (S)

Department of Nuclear Medicine, Friedrich-Alexander-University (FAU) Erlangen-Nürnberg and Universitätsklinikum Erlangen, Erlangen, Germany.

Arif B Ekici (AB)

Institute of Human Genetics, Friedrich-Alexander-University (FAU) Erlangen-Nürnberg and Universitätsklinikum Erlangen, Erlangen, Germany.

Christopher D Buckley (CD)

Kennedy Institute of Rheumatology, University of Oxford, Oxford, UK.

Adam P Croft (AP)

Rheumatology Research Group, Institute for Inflammation and Ageing, College of Medical and Dental Sciences, University of Birmingham, Queen Elizabeth Hospital, Birmingham, UK.
NIHR Birmingham Biomedical Research Center and Clinical Research Facility, University of Birmingham, Queen Elizabeth Hospital, Birmingham, UK.

Torsten Kuwert (T)

Department of Nuclear Medicine, Friedrich-Alexander-University (FAU) Erlangen-Nürnberg and Universitätsklinikum Erlangen, Erlangen, Germany.

Olaf Prante (O)

Department of Nuclear Medicine, Friedrich-Alexander-University (FAU) Erlangen-Nürnberg and Universitätsklinikum Erlangen, Erlangen, Germany.

Juan D Cañete (JD)

Hospital Clínic and IDIBAPS, Barcelona, Spain.

Georg Schett (G)

Department of Internal Medicine 3 - Rheumatology and Immunology, Friedrich-Alexander-University (FAU) Erlangen-Nürnberg and Universitätsklinikum Erlangen, Erlangen, Germany.
Deutsches Zentrum für Immuntherapie (DZI), Friedrich-Alexander-University (FAU) Erlangen-Nürnberg and Universitätsklinikum Erlangen, Erlangen, Germany.

Andreas Ramming (A)

Department of Internal Medicine 3 - Rheumatology and Immunology, Friedrich-Alexander-University (FAU) Erlangen-Nürnberg and Universitätsklinikum Erlangen, Erlangen, Germany. andreas.ramming@uk-erlangen.de.
Deutsches Zentrum für Immuntherapie (DZI), Friedrich-Alexander-University (FAU) Erlangen-Nürnberg and Universitätsklinikum Erlangen, Erlangen, Germany. andreas.ramming@uk-erlangen.de.

Classifications MeSH